PF 477736 Options
Watch Closely (one)crofelemer increases levels of pazopanib by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Observe. Crofelemer has the possible to inhibit CYP3A4 at concentrations predicted while in the intestine; not likely to inhibit systemically because minimally absorbed.Really serious - Use Substitute (1)aluminum hydroxi